India Unveils Indigenous H5N1 Vaccine for Poultry After Bhopal Trials
India has unveiled an inactivated H5N1 vaccine developed by ICAR-NIHSAD in Bhopal for chickens. The vaccine targets clade 2.3.2.1a, and institute-reported trials found protection lasting up to six months, although wider rollout arrangements have not yet been detailed.

India has unveiled its first indigenous inactivated vaccine for chickens against the H5N1 strain of highly pathogenic avian influenza, marking a new step in the country's efforts to strengthen poultry disease control. The vaccine was developed by scientists at the ICAR-National Institute of High Security Animal Diseases (ICAR-NIHSAD) in Bhopal and targets H5N1 clade 2.3.2.1a, a strain associated with many outbreaks in Indian poultry.
Union Agriculture Minister Shivraj Singh Chouhan dedicated the vaccine technology to the nation at ICAR-NIHSAD on November 20. The development is intended to give animal-health authorities and the poultry sector an additional tool against a disease that can cause severe losses on farms and disrupt trade in poultry products.
Vaccine targets a strain circulating in Indian poultry
The vaccine is an inactivated formulation designed for chickens. The government said the targeted clade has been responsible for most H5N1 bird flu outbreaks in chickens in India. Until now, a specific commercial vaccine for H5N1 clade 2.3.2.1a was not available in the country, according to the Agriculture Ministry's announcement.
Matching a vaccine to strains circulating in poultry is important because avian influenza viruses can change over time. A locally developed candidate gives Indian researchers and animal-health agencies a platform focused on the strain identified as a priority in domestic surveillance. Its usefulness will depend on how it is evaluated, manufactured and incorporated into disease-control programmes.
Institute reports protection in experimental trials
ICAR-NIHSAD told The Times of India that experimental trials showed the vaccine protected chickens for up to six months and prevented transmission to other chickens kept in contact with vaccinated birds. The institute also said the vaccine met sterility, safety and efficacy standards in trials involving specific-pathogen-free layer and grower chickens.
These are findings reported by the developing institute. They should not be confused with evidence from a nationwide field vaccination programme. Independent assessment, regulatory requirements, manufacturing capacity and field performance will all matter before the vaccine's broader impact can be judged.
Why poultry disease control matters to the economy
Highly pathogenic avian influenza can spread rapidly among susceptible bird populations. Infected flocks may experience very high mortality, while containment measures can require movement restrictions and the removal of affected birds. Farmers can face direct losses from the loss of stock as well as indirect costs from disrupted sales, transport and market access.
The Agriculture Ministry said India has recorded more than 500 combined H5N1 and H5N8 outbreaks since the disease was first detected in the country in 2006. It cited estimates that the 2006 outbreak caused direct and indirect losses of ₹2,200 crore to ₹3,000 crore. These figures underline why prevention and rapid response are important for a poultry industry that supports farmers, suppliers, processors and retailers.
Vaccination would complement surveillance and biosecurity
A vaccine is not a substitute for disease surveillance, laboratory testing, farm biosecurity or prompt reporting of unusual bird deaths. Effective control generally relies on several measures working together, including monitoring poultry health, limiting contact with wild birds, cleaning and disinfection, and following veterinary directions when infection is suspected.
The vaccine announcement also does not mean that all poultry will be vaccinated immediately. The government has yet to provide a detailed public schedule for commercial production, distribution, farm-level deployment or vaccination protocols. Poultry producers will need to follow official guidance from animal-husbandry authorities rather than assume that the new technology is already available for routine use.
What happens after the unveiling
The next steps to watch are the arrangements for scale-up, quality control, regulatory oversight and integration with India's avian-influenza response plans. Field evidence across different poultry settings will help establish how consistently the vaccine protects birds under practical farm conditions.
For now, the unveiling represents a domestic research milestone and a potential addition to India's poultry-health toolkit. The value of the H5N1 vaccine will ultimately be measured not only by its laboratory results, but by safe production, appropriate deployment and its ability to reduce outbreaks and economic disruption when used alongside established control measures.
Sources
Written with automated tools from the sources above and published without editor review. Spotted an error? Tell us · Corrections Policy
Related stories

India and EU finish Horizon Europe talks, opening a path to direct research funding
India and the European Union have concluded negotiations on India's association with Horizon Europe, but researchers will gain access to the new funding arrangements only after the agreement is signed and procedures are completed.

Tiny crystals point to an ancient mountain system hidden beneath Antarctic ice
Researchers analysed 1,712 zircon grains from Antarctic sediments and found evidence of Himalayan-scale mountain building during Gondwana's formation, with possible links to ancient ocean chemistry.

India Prepares to Unveil Indigenous H5N1 Vaccine for Chickens
India is set to dedicate its first home-developed inactivated H5N1 vaccine for chickens on November 20. Developed by ICAR-NIHSAD in Bhopal, it targets the Clade 2.3.2.1a strain linked to many poultry outbreaks.
India Puts Integrated Reservoir Management at the Centre of Its Water-Security Debate
A national conference in Pune has brought government agencies, researchers and engineers together to discuss reservoir coordination, climate resilience, dam safety and digital water-management tools.
